ADIPOQ and breast carcinoma: Adiponectin was reported to bind to receptors on the cell membrane, activate the downstream sestrin 2/AMPK pathway, inhibit ER stress, suppress inflammatory activity, inhibit proliferation, and promote apoptosis in breast cancer cell lines MCF-7, MDA-MB-231, and T47D [64].